{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:52:24Z","timestamp":1782564744794,"version":"3.54.5"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Ovarian cancer is the second most common gynecologic cancer in the United States and the deadliest gynecologic cancer worldwide, with a 5-year survival rate of less than 50%. Because of its vague symptoms, more than half of patients present with advanced disease and metastasis. This article reviews the epidemiology, pathogenesis, risk factors, screening, presentation, and diagnosis of ovarian cancer, in addition to providing an overview of the standard approach to treatment and novel targeted biologic therapies.<\/jats:p>","DOI":"10.1097\/01.jaa.0000000000000042","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T13:01:17Z","timestamp":1719320477000},"page":"32-36","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Ovarian cancer"],"prefix":"10.1097","volume":"37","author":[{"given":"Tessa","family":"Thull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Kempton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"R4-20250605","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ygyno.2021.07.011","article-title":"Disparities in ovarian cancer treatment and overall survival according to race: an update","volume":"612","author":"Huffman","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"suppl 24","key":"R5-20250605","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1002\/cncr.31027","article-title":"Disparities in ovarian cancer survival in the United States (2001\u20132009): findings from the CONCORD-2 study","volume":"123","author":"Stewart","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"R6-20250605","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3322\/caac.21559","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bpobgyn.2020.02.010","article-title":"Ovarian cancer screening: current status and future directions","volume":"65","author":"Nash","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"R9-20250605","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/AOG.0000000000002317","article-title":"Cost of care for the initial management of ovarian cancer","volume":"130","author":"Bercow","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"R10-20250605","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian cancer: an integrated review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin Oncol Nurs"},{"issue":"2","key":"R11-20250605","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ijgc-2020-002018","article-title":"Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management","volume":"31","author":"Al Harbi","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"R12-20250605","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"issue":"25","key":"R13-20250605","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/onc.2016.509","article-title":"A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNF\u03b1-TGF\u03b1-EGFR","volume":"36","author":"Lau","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"R14-20250605","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1369\/0022155417742897","article-title":"Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review","volume":"66","author":"van Baal","year":"2018","journal-title":"J Histochem Cytochem"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00066","article-title":"Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women","volume":"1","author":"Kurian","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"R16-20250605","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ygyno.2018.06.022","article-title":"Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients","volume":"150","author":"Deng","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"6","key":"R17-20250605","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3892\/mco.2014.397","article-title":"Features of ovarian cancer in Lynch syndrome (review)","volume":"2","author":"Nakamura","year":"2014","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"R18-20250605","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gmit.2017.08.003","article-title":"Clinical implication for endometriosis associated with ovarian cancer","volume":"6","author":"Torng","year":"2017","journal-title":"Gynecol Minim Invasive Ther"},{"issue":"1","key":"R19-20250605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies","volume":"185","author":"Rasmussen","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"5","key":"R20-20250605","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/joim.12747","article-title":"The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence","volume":"283","author":"Troisi","year":"2018","journal-title":"J Intern Med"},{"issue":"6","key":"R21-20250605","doi-asserted-by":"crossref","first-page":"e200421","DOI":"10.1001\/jamaoncol.2020.0421","article-title":"Association between breastfeeding and ovarian cancer risk","volume":"6","author":"Babic","year":"2020","journal-title":"JAMA Oncol"},{"key":"R23-20250605","first-page":"362","article-title":"Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study","author":"Iversen","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"R24-20250605","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/01443615.2020.1789960","article-title":"Ever-use of the intra-uterine device and the risk of ovarian cancer","volume":"41","author":"Balayla","year":"2021","journal-title":"J Obstet Gynaecol"},{"issue":"11","key":"R25-20250605","first-page":"937","article-title":"Diagnosis and management of ovarian cancer","volume":"93","author":"Doubeni","year":"2016","journal-title":"Am Fam Physician"},{"issue":"2","key":"R26-20250605","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2020.05.002","article-title":"Ovarian cancer symptoms, routes to diagnosis and survival\u2014population cohort study in the \u2018no screen\u2019 arm of the UK collaborative trial of ovarian cancer screening (UKCTOCS)","volume":"158","author":"Dilley","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R27-20250605","first-page":"1","article-title":"Sister Mary Joseph Nodule as a first manifestation of a metastatic ovarian cancer","volume":"2016","author":"Calongos","year":"2016","journal-title":"Case Rep Obstet Gynecol"},{"issue":"6","key":"R28-20250605","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hoc.2018.07.010","article-title":"Diagnosis and treatment of ovarian cancer","volume":"32","author":"Orr","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"15","key":"R29-20250605","article-title":"Impact of pleural effusion in ovarian cancer: a retrospective study in Lleida, Spain","volume":"39","author":"Murata","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"R30-20250605","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/0969141316680381","article-title":"The bimanual ovarian palpation examination in the prostate, lung, colorectal and ovarian cancer screening trial: performance and complications","volume":"24","author":"Doroudi","year":"2017","journal-title":"J Med Screen"},{"issue":"11","key":"R31-20250605","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/jog.14427","article-title":"Serum CA19\u20139, CA-125 and CEA as tumor markers for mucinous ovarian tumors","volume":"46","author":"Lertkhachonsuk","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"issue":"12","key":"R32-20250605","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.3390\/cancers12123730","article-title":"CA125 and ovarian cancer: a comprehensive review","volume":"12","author":"Charkhchi","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"R33-20250605","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ygyno.2012.03.048","article-title":"Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis","volume":"126","author":"Dodge","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"R34-20250605","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2018.01.029","article-title":"Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): good, bad, or just expensive","volume":"149","author":"Naumann","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"R35-20250605","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/1940-6207.CAPR-10-0195","article-title":"Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens","volume":"4","author":"Cramer","year":"2011","journal-title":"Cancer Prev Res"},{"issue":"2","key":"R36-20250605","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2016.08.334","article-title":"Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up","volume":"143","author":"Pinsky","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"10290","key":"R37-20250605","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"R39-20250605","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","article-title":"Advances in ovarian cancer therapy","volume":"81","author":"Cortez","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"R42-20250605","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11912-019-0816-0","article-title":"Novel approaches to ovarian cancer screening","volume":"21","author":"Nebgen","year":"2019","journal-title":"Curr Oncol Rep"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000000000000042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:01:28Z","timestamp":1749153688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000000000000042"}},"subtitle":["A review for primary care providers"],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000000000000042","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,25]]}}}